WallStSmart
TARA

Protara Therapeutics Inc

NASDAQ: TARA · HEALTHCARE · BIOTECHNOLOGY

$5.33
+3.09% today

Updated 2026-04-30

Market cap
$273.67M
P/E ratio
P/S ratio
EPS (TTM)
$-1.34
Dividend yield
52W range
$3 – $8
Volume
1.0M

Protara Therapeutics Inc (TARA) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+12.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+11.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-1.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-2.6%
2026-03-10
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.38-21.8%$5.75$5.60-2.6%
2025-10-30$-0.31+17.9%$5.20$5.18-0.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.31$-0.38-21.8%
2025-09-30$-0.38$-0.31+17.9%
2025-06-30$-0.40$-0.35+12.5%
2025-03-31$-0.48$-0.29+39.3%
2024-12-31$-0.57$-0.43+23.9%$332000.00-72.5%
2024-09-30$-0.52$-0.50+3.4%
2024-06-30$-0.80$-0.45+43.8%
2024-03-31$-0.92$-0.97-5.4%
2023-12-31$-0.92$-0.90+2.2%$1.21M
2023-09-30$-0.98$-0.87+11.2%
2023-06-30$-0.87$-1.00-14.9%
2023-03-31$-0.88$-0.80+9.1%

Frequently asked questions

Has Protara Therapeutics Inc beaten earnings estimates?
Protara Therapeutics Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +12.0% over the last 4 quarters.
How does TARA stock react to earnings?
TARA stock has moved an average of -1.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.